Regeneron, US75886F1075

Regeneron stock: Management schedules healthcare conferences

Published on 11/04/2026 at 17:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Regeneron stock is heading into a new round of investor presentations. Management will appear at Jefferies, Evercore and Citi events from November 17 to December 2.

Fresh investor dates for Regeneron

  • Management will present at healthcare conferences hosted by Jefferies, Evercore and Citi.
  • Regeneron says it has nearly 50 candidates in development and 16 medicines developed in-house have been approved.
  • The events may give investors further insight into the company's pipeline and development priorities.
Regeneron, US75886F1075, Illustration mit AI erstellt.

Regeneron Pharmaceuticals will webcast management presentations at three healthcare investor conferences in November and December. The company announced the schedule on November 2 in a Regeneron Pharmaceuticals investor release.

Management puts dates on calendar

Regeneron will take part in the Jefferies Global Healthcare Conference in London on Tuesday, November 17, at 2:00 p.m. GMT, or 9:00 a.m. Eastern Time. The company is also scheduled for the Evercore Healthcare Conference on Tuesday, December 1, at 1:45 p.m. Eastern Time, followed by Citi's Global Healthcare Conference on Wednesday, December 2, at 9:40 a.m. Eastern Time.

Regeneron said the sessions will be available through its investor website. Replays and transcripts are expected to remain available for at least 30 days, giving investors access to management commentary after each event.

Pipeline remains central

Regeneron's corporate website highlights nearly 50 candidates in development and 16 approved medicines developed in-house. The scheduled appearances therefore give investors additional points at which management can discuss research priorities, clinical progress and the commercial outlook for its medicines.

Current trading context

Regeneron stock traded at 853.70 euros on Lang & Schwarz at 17:32 CET on Wednesday, November 4, 2026. The real-time quote of Regeneron stock is available on the company snapshot page.

Regeneron Pharmaceuticals at a glance

  • Company: Regeneron Pharmaceuticals, Inc.
  • ISIN: US75886F1075
  • Ticker: REGN
  • Home exchange: Nasdaq
  • Lang & Schwarz quote: 853.70 euros at 17:32 CET on November 4, 2026

Regeneron's US market setting can be followed through the S&P 500 market topic.

More news and analyses on Regeneron stock.

Disclaimer...
en | US75886F1075 | REGENERON | boerse | 70458330 |